Archive Category: Green Zone Fortunes Updates

Disruption Alert: Biopharma Co.’s Just-Approved Medical Innovation to Reshape Lucrative ADHD Market

When I learned about the latest medical innovation of the company I’m sharing with you today, I researched the stock and saw how it stacks up in our Green Zone Ratings system. It was clear that I needed to share it with you, my Green Zone Fortunes readers. I told my co-editor Charles Sizemore and my team that I had to write this issue. I was that pumped to tell you about this stock.

Read More

Keep Holding Twist Bioscience (TWST)

I’ve been saying that our “Imperium” stock, Twist Bioscience Corp. (Nasdaq: TWST), has the potential to be a $1,000 stock, and that hasn’t changed.

Read More

Fed Gives Us 8 Trillion Reasons to Focus on Gold: Agnico Eagle Mines Update

This week, I discuss how the Federal Reserve has given us trillions of reasons to focus on gold — and I do a deep dive on our gold miner Agnico Eagle (NYSE: AEM) after its latest earnings announcement. I also explain why chief investment strategist Adam O’Dell and I are still bullish on our competitive gaming play, Turtle Beach Corp. (Nasdaq: HEAR) — including the latest news about an activist investor.

Read More

Sign-up == X1904104

Conquering the Market Starts Here ...

In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!

Watchlist